These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 11522011)

  • 21. [Quality control of ISI/INR system in oral anticoagulant therapy].
    Kazama M
    Rinsho Ketsueki; 1990 Jun; 31(6):769-75. PubMed ID: 2214167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasma.
    Koestenberger M; Gallistl S; Muntean W; Leschnik B; Fritsch P; Cvirn G
    Thromb Haemost; 2005 Jul; 94(1):69-74. PubMed ID: 16113786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index.
    Magnusson M; Sten-Linder M; Bergquist A; Rajani R; Kechagias S; Fischler B; Németh A; Lindahl TL
    Thromb Res; 2013 Sep; 132(3):346-51. PubMed ID: 23993902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
    Mischke R; Junker J; Deegen E
    Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents.
    Kazama M; Suzuki S; Abe T; Tahara C; Shimazu C; Akiyama Y; Higashi K; Ishiguro I; Kimura T; Motoi S
    Thromb Haemost; 1990 Dec; 64(4):535-41. PubMed ID: 2084938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time.
    Koestenberger M; Cvirn G; Gallistl S; Muntean W
    Blood Coagul Fibrinolysis; 2004 Oct; 15(8):693-7. PubMed ID: 15613925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results.
    Webster PS; Oleson FB; Paterson DL; Arkin CF; Mangili A; Craven DE; Adcock DM; Lindfield KC; Knapp AG; Martone WJ
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):32-8. PubMed ID: 18180613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral anticoagulant therapy and international normalized ratios in swine.
    McGlasson DL; Brickey DA; Doe RH
    Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The factors that influence the consistency of international normalized ratio of prothrombin time].
    Su W; Ren FQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):196-8. PubMed ID: 12905903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
    Adcock DM; Johnston M
    Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin.
    Becker DM; Humphries JE; Walker FB; DeMong LK; Bopp JS; Acker MN
    Arch Pathol Lab Med; 1993 Jun; 117(6):602-5. PubMed ID: 8503731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prothrombin time standardisation in canine samples with regard to inter-batch and inter-reagent variability.
    Mischke R
    Vet J; 2011 Jun; 188(3):301-6. PubMed ID: 20655250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor.
    Elg M; Carlsson S; Gustafsson D
    Thromb Res; 2001 Feb; 101(3):145-57. PubMed ID: 11228338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human activated protein C, heparin and melagatran in umbilical cord versus adult plasma.
    Koestenberger M; Cvirn G; Gallistl S; Kutschera J; Muntean W
    Acta Paediatr; 2005 Jul; 94(7):884-9. PubMed ID: 16188810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring the new antithrombotic drugs.
    Walenga JM; Hoppensteadt DA
    Semin Thromb Hemost; 2004 Dec; 30(6):683-95. PubMed ID: 15630675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ISI/INR system in Japan: experience from simultaneous measurement of the same plasma at four different laboratories.
    Uetsuka Y; Sakuragawa N; Wada H; Aizawa Y; Aosaki M
    Semin Thromb Hemost; 2000; 26(1):109-12. PubMed ID: 10805291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.